Paul S. Albert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Paul S. Albert has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Dean A. Follmann
Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, U.S.A.
2 shared publicationsJoanna H. Shih
Biometric Research Branch, National Cancer Institute, Executive Plaza North, Room 8136, Bethesda, Maryland 20892‐7434, U.S.A.
2 shared publicationsLisa M. McShane
Biometric Research Branch, National Cancer Institute, Executive Plaza North, Room 8136, Bethesda, Maryland 20892–7434, U.S.A.
2 shared publicationsDuminda Ratnasinghe
1 shared publicationEdward B. Suh
Division of Computational Biosciences, Center for Information Technology, National Institutes of Health, Bethesda, Maryland 20892, U.S.A.
1 shared publicationEdward L. Korn
Biometric Research Branch, National Cancer Institute, Executive Plaza North, Room 8136, Bethesda, Maryland 20892–7434, U.S.A.
1 shared publication
Latest Publications
- 13 March 2009
- Published by Wiley in Statistics in Medicine
- Vol. 28 (8) , 1301-1314
A finite mixture survival model to characterize risk groups of neuroblastoma
Neuroblastoma is a childhood cancer with patients experiencing heterogeneous survival outcomes despite aggressive treatment. Disease outcomes range from early death to spontaneous regression of the tumor followed by cure. Owing to this heterogeneity, it is of interest to identify patients with similar types of neuroblastoma so that specific types of treatment can be developed. Oncologists are especially interested in identifying patients who will be cured so that the minimum amount of a potentially toxic treatment can be given to this group of patients. We analyze a large cohort of neuroblastoma patients and develop a finite mixture model that uses covariates to predict the probability of being in a cure group or other (one or more) risk groups. A prediction method is developed that uses the estimated probabilities to assign a patient to different risk groups. The robustness of the model and the prediction method is examined via simulation by looking at misclassification rates under misspecified models. Published in 2009 by John Wiley & Sons, Ltd.
- 13 March 2009
- Published by Wiley in Statistics in Medicine
- Vol. 28 (8) , 1301-1314
A finite mixture survival model to characterize risk groups of neuroblastoma
Neuroblastoma is a childhood cancer with patients experiencing heterogeneous survival outcomes despite aggressive treatment. Disease outcomes range from early death to spontaneous regression of the tumor followed by cure. Owing to this heterogeneity, it is of interest to identify patients with similar types of neuroblastoma so that specific types of treatment can be developed. Oncologists are especially interested in identifying patients who will be cured so that the minimum amount of a potentially toxic treatment can be given to this group of patients. We analyze a large cohort of neuroblastoma patients and develop a finite mixture model that uses covariates to predict the probability of being in a cure group or other (one or more) risk groups. A prediction method is developed that uses the estimated probabilities to assign a patient to different risk groups. The robustness of the model and the prediction method is examined via simulation by looking at misclassification rates under misspecified models. Published in 2009 by John Wiley & Sons, Ltd.
- 19 December 2008
- Published by Wiley in Statistics in Medicine
- Vol. 28 (5) , 780-797
Estimating diagnostic accuracy of multiple binary tests with an imperfect reference standard
The goal in diagnostic medicine is often to estimate the diagnostic accuracy of multiple experimental tests relative to a gold standard reference. When a gold standard reference is not available, investigators commonly use an imperfect reference standard. This paper proposes methodology for estimating the diagnostic accuracy of multiple binary tests with an imperfect reference standard when information about the diagnostic accuracy of the imperfect test is available from external data sources. We propose alternative joint models for characterizing the dependence between the experimental tests and discuss the use of these models for estimating individual‐test sensitivity and specificity as well as prevalence and multivariate post‐test probabilities (predictive values). We show using analytical and simulation techniques that, as long as the sensitivity and specificity of the imperfect test are high, inferences on diagnostic accuracy are robust to misspecification of the joint model. The methodology is demonstrated with a study examining the diagnostic accuracy of various HIV‐antibody tests for HIV. Published in 2008 by John Wiley & Sons, Ltd.
- 19 December 2008
- Published by Wiley in Statistics in Medicine
- Vol. 28 (5) , 780-797
Estimating diagnostic accuracy of multiple binary tests with an imperfect reference standard
The goal in diagnostic medicine is often to estimate the diagnostic accuracy of multiple experimental tests relative to a gold standard reference. When a gold standard reference is not available, investigators commonly use an imperfect reference standard. This paper proposes methodology for estimating the diagnostic accuracy of multiple binary tests with an imperfect reference standard when information about the diagnostic accuracy of the imperfect test is available from external data sources. We propose alternative joint models for characterizing the dependence between the experimental tests and discuss the use of these models for estimating individual‐test sensitivity and specificity as well as prevalence and multivariate post‐test probabilities (predictive values). We show using analytical and simulation techniques that, as long as the sensitivity and specificity of the imperfect test are high, inferences on diagnostic accuracy are robust to misspecification of the joint model. The methodology is demonstrated with a study examining the diagnostic accuracy of various HIV‐antibody tests for HIV. Published in 2008 by John Wiley & Sons, Ltd.
- 2 December 2005
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 61 (4) , 1115-1120
On Analyzing Circadian Rhythms Data Using Nonlinear Mixed Models with Harmonic Terms
Summary Wang, Ke, and Brown (2003, Biometrics59, 804–812) developed a smoothing‐based approach for modeling circadian rhythms with random effects. Their approach is flexible in that fixed and random covariates can affect both the amplitude and phase shift of a nonparametrically smoothed periodic function. In motivating their approach, Wang et al. stated that a simple sinusoidal function is too restrictive. In addition, they stated that “although adding harmonics can improve the fit, it is difficult to decide how many harmonics to include in the model, and the results are difficult to interpret.” We disagree with the notion that harmonic models cannot be a useful tool in modeling longitudinal circadian rhythm data. In this note, we show how nonlinear mixed models with harmonic terms allow for a simple and flexible alternative to Wang et al.'s approach. We show how to choose the number of harmonics using penalized likelihood to flexibly model circadian rhythms and to estimate the effect of covariates on the rhythms. We fit harmonic models to the cortisol circadian rhythm data presented by Wang et al. to illustrate our approach. Furthermore, we evaluate the properties of our procedure with a small simulation study. The proposed parametric approach provides an alternative to Wang et al.'s semiparametric approach and has the added advantage of being easy to implement in most statistical software packages.
- 2 December 2005
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 61 (4) , 1115-1120
On Analyzing Circadian Rhythms Data Using Nonlinear Mixed Models with Harmonic Terms
Summary Wang, Ke, and Brown (2003, Biometrics59, 804–812) developed a smoothing‐based approach for modeling circadian rhythms with random effects. Their approach is flexible in that fixed and random covariates can affect both the amplitude and phase shift of a nonparametrically smoothed periodic function. In motivating their approach, Wang et al. stated that a simple sinusoidal function is too restrictive. In addition, they stated that “although adding harmonics can improve the fit, it is difficult to decide how many harmonics to include in the model, and the results are difficult to interpret.” We disagree with the notion that harmonic models cannot be a useful tool in modeling longitudinal circadian rhythm data. In this note, we show how nonlinear mixed models with harmonic terms allow for a simple and flexible alternative to Wang et al.'s approach. We show how to choose the number of harmonics using penalized likelihood to flexibly model circadian rhythms and to estimate the effect of covariates on the rhythms. We fit harmonic models to the cortisol circadian rhythm data presented by Wang et al. to illustrate our approach. Furthermore, we evaluate the properties of our procedure with a small simulation study. The proposed parametric approach provides an alternative to Wang et al.'s semiparametric approach and has the added advantage of being easy to implement in most statistical software packages.
- 31 August 2005
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 61 (3) , 879-880
Letter to the Editor
- 31 August 2005
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 61 (3) , 879-880
Letter to the Editor
- 3 March 2005
- Published by Oxford University Press (OUP) in Journal of the Royal Statistical Society Series C: Applied Statistics
- Vol. 54 (4) , 707-720
Modelling Longitudinal Semicontinuous Emesis Volume Data with Serial Correlation in an Acupuncture Clinical Trial
Summary: In longitudinal studies, we are often interested in modelling repeated assessments of volume over time. Our motivating example is an acupuncture clinical trial in which we compare the effects of active acupuncture, sham acupuncture and standard medical care on chemotherapy-induced nausea in patients being treated for advanced stage breast cancer. An important end point for this study was the daily measurement of the volume of emesis over a 14-day follow-up period. The repeated volume data contained many 0s, had apparent serial correlation and had missing observations, making analysis challenging. The paper proposes a two-part latent process model for analysing the emesis volume data which addresses these challenges. We propose a Monte Carlo EM algorithm for parameter estimation and we use this methodology to show the beneficial effects of acupuncture on reducing the volume of emesis in women being treated for breast cancer with chemotherapy. Through simulations, we demonstrate the importance of correctly modelling the serial correlation for making conditional inference. Further, we show that the correct model for the correlation structure is less important for making correct inference on marginal means.
- 3 March 2005
- Published by Oxford University Press (OUP) in Journal of the Royal Statistical Society Series C: Applied Statistics
- Vol. 54 (4) , 707-720
Modelling Longitudinal Semicontinuous Emesis Volume Data with Serial Correlation in an Acupuncture Clinical Trial
Summary: In longitudinal studies, we are often interested in modelling repeated assessments of volume over time. Our motivating example is an acupuncture clinical trial in which we compare the effects of active acupuncture, sham acupuncture and standard medical care on chemotherapy-induced nausea in patients being treated for advanced stage breast cancer. An important end point for this study was the daily measurement of the volume of emesis over a 14-day follow-up period. The repeated volume data contained many 0s, had apparent serial correlation and had missing observations, making analysis challenging. The paper proposes a two-part latent process model for analysing the emesis volume data which addresses these challenges. We propose a Monte Carlo EM algorithm for parameter estimation and we use this methodology to show the beneficial effects of acupuncture on reducing the volume of emesis in women being treated for breast cancer with chemotherapy. Through simulations, we demonstrate the importance of correctly modelling the serial correlation for making conditional inference. Further, we show that the correct model for the correlation structure is less important for making correct inference on marginal means.
- 7 June 2004
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 60 (2) , 427-435
A Cautionary Note on the Robustness of Latent Class Models for Estimating Diagnostic Error without a Gold Standard
Summary. Modeling diagnostic error without a gold standard has been an active area of biostatistical research. In a majority of the approaches, model‐based estimates of sensitivity, specificity, and prevalence are derived from a latent class model in which the latent variable represents an individual's true unobserved disease status. For simplicity, initial approaches assumed that the diagnostic test results on the same subject were independent given the true disease status (i.e., the conditional independence assumption). More recently, various authors have proposed approaches for modeling the dependence structure between test results given true disease status. This note discusses a potential problem with these approaches. Namely, we show that when the conditional dependence between tests is misspecified, estimators of sensitivity, specificity, and prevalence can be biased. Importantly, we demonstrate that with small numbers of tests, likelihood comparisons and other model diagnostics may not be able to distinguish between models with different dependence structures. We present asymptotic results that show the generality of the problem. Further, data analysis and simulations demonstrate the practical implications of model misspecification. Finally, we present some guidelines about the use of these models for practitioners.
- 7 June 2004
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 60 (2) , 427-435
A Cautionary Note on the Robustness of Latent Class Models for Estimating Diagnostic Error without a Gold Standard
Summary. Modeling diagnostic error without a gold standard has been an active area of biostatistical research. In a majority of the approaches, model‐based estimates of sensitivity, specificity, and prevalence are derived from a latent class model in which the latent variable represents an individual's true unobserved disease status. For simplicity, initial approaches assumed that the diagnostic test results on the same subject were independent given the true disease status (i.e., the conditional independence assumption). More recently, various authors have proposed approaches for modeling the dependence structure between test results given true disease status. This note discusses a potential problem with these approaches. Namely, we show that when the conditional dependence between tests is misspecified, estimators of sensitivity, specificity, and prevalence can be biased. Importantly, we demonstrate that with small numbers of tests, likelihood comparisons and other model diagnostics may not be able to distinguish between models with different dependence structures. We present asymptotic results that show the generality of the problem. Further, data analysis and simulations demonstrate the practical implications of model misspecification. Finally, we present some guidelines about the use of these models for practitioners.
- 11 December 2003
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 59 (4) , 897-906
Modeling Tumor Growth with Random Onset
Summary. The longitudinal assessment of tumor volume is commonly used as an endpoint in small animal studies in cancer research. Groups of genetically identical mice are injected with mutant cells from clones developed with different mutations. The interest is on comparing tumor onset (i.e., the time of tumor detection) and tumor growth after onset, between mutation groups. This article proposes a class of linear and nonlinear growth models for jointly modeling tumor onset and growth in this situation. Our approach allows for interval‐censored time of onset and missing‐at‐random dropout due to early sacrifice, which are common situations in animal research. We show that our approach has good small‐sample properties for testing and is robust to some key unverifiable modeling assumptions. We illustrate this methodology with an application examining the effect of different mutations on tumorigenesis.
- 11 December 2003
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 59 (4) , 897-906
Modeling Tumor Growth with Random Onset
Summary. The longitudinal assessment of tumor volume is commonly used as an endpoint in small animal studies in cancer research. Groups of genetically identical mice are injected with mutant cells from clones developed with different mutations. The interest is on comparing tumor onset (i.e., the time of tumor detection) and tumor growth after onset, between mutation groups. This article proposes a class of linear and nonlinear growth models for jointly modeling tumor onset and growth in this situation. Our approach allows for interval‐censored time of onset and missing‐at‐random dropout due to early sacrifice, which are common situations in animal research. We show that our approach has good small‐sample properties for testing and is robust to some key unverifiable modeling assumptions. We illustrate this methodology with an application examining the effect of different mutations on tumorigenesis.
- 1 September 2002
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 58 (3) , 576-585
Design of a Binary Biomarker Study from the Results of a Pilot Study
Summary. Biomarkers are increasingly used in clinical and epidemiologic studies. Prior to these studies, small pilot studies are often conducted to assess the reproducibility of the biomarker. This article discusses how the results of a pilot study can be used to design subsequent studies when the biomarker is a binary assessment. We consider situations in which the pilot study has two factors (e.g., laboratory and individual) that are either crossed or nested. We discuss how binary random‐effects models can be used for estimating the sources of variation and how parameter estimates from these models can be used to appropriately design future studies. We also show that fitting a linear variance components model that ignores the binary nature of the data is a simple alternative method that results in nearly unbiased and moderately efficient estimators of important design parameters. We illustrate the methodology with data from a study assessing the reproducibility of p53 immunohistochemistry in bladder tumors.
- 1 September 2002
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 58 (3) , 576-585
Design of a Binary Biomarker Study from the Results of a Pilot Study
Summary. Biomarkers are increasingly used in clinical and epidemiologic studies. Prior to these studies, small pilot studies are often conducted to assess the reproducibility of the biomarker. This article discusses how the results of a pilot study can be used to design subsequent studies when the biomarker is a binary assessment. We consider situations in which the pilot study has two factors (e.g., laboratory and individual) that are either crossed or nested. We discuss how binary random‐effects models can be used for estimating the sources of variation and how parameter estimates from these models can be used to appropriately design future studies. We also show that fitting a linear variance components model that ignores the binary nature of the data is a simple alternative method that results in nearly unbiased and moderately efficient estimators of important design parameters. We illustrate the methodology with data from a study assessing the reproducibility of p53 immunohistochemistry in bladder tumors.
- 1 September 2002
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 58 (3) , 631-642
A Latent Autoregressive Model for Longitudinal Binary Data Subject to Informative Missingness
Summary. Longitudinal clinical trials often collect long sequences of binary data. Our application is a recent clinical trial in opiate addicts that examined the effect of a new treatment on repeated binary urine tests to assess opiate use over an extended follow‐up. The dataset had two sources of missingness: dropout and intermittent missing observations. The primary endpoint of the study was comparing the marginal probability of a positive urine test over follow‐up across treatment arms. We present a latent autoregressive model for longitudinal binary data subject to informative missingness. In this model, a Gaussian autoregressive process is shared between the binary response and missing‐data processes, thereby inducing informative missingness. Our approach extends the work of others who have developed models that link the various processes through a shared random effect but do not allow for autocorrelation. We discuss parameter estimation using Monte Carlo EM and demonstrate through simulations that incorporating within‐subject autocorrelation through a latent autoregressive process can be very important when longitudinal binary data is subject to informative missingness. We illustrate our new methodology using the opiate clinical trial data.
- 1 September 2002
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 58 (3) , 631-642
A Latent Autoregressive Model for Longitudinal Binary Data Subject to Informative Missingness
Summary. Longitudinal clinical trials often collect long sequences of binary data. Our application is a recent clinical trial in opiate addicts that examined the effect of a new treatment on repeated binary urine tests to assess opiate use over an extended follow‐up. The dataset had two sources of missingness: dropout and intermittent missing observations. The primary endpoint of the study was comparing the marginal probability of a positive urine test over follow‐up across treatment arms. We present a latent autoregressive model for longitudinal binary data subject to informative missingness. In this model, a Gaussian autoregressive process is shared between the binary response and missing‐data processes, thereby inducing informative missingness. Our approach extends the work of others who have developed models that link the various processes through a shared random effect but do not allow for autocorrelation. We discuss parameter estimation using Monte Carlo EM and demonstrate through simulations that incorporating within‐subject autocorrelation through a latent autoregressive process can be very important when longitudinal binary data is subject to informative missingness. We illustrate our new methodology using the opiate clinical trial data.
- Open Access
- 13 August 2002
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 2 (1) , 8
Use of complementary/alternative therapies by women with advanced-stage breast cancer
This study sought to describe the pattern of complementary/alternative medicine (CAM) use among a group of patients with advanced breast cancer, to examine the main reasons for their CAM use, to identify patient's information sources and their communication pattern with their physicians. Face-to-face structured interviews of patients with advanced-stage breast cancer at a comprehensive oncology center. Seventy three percent of patients used CAM; relaxation/meditative techniques and herbal medicine were the most common. The most commonly cited primary reason for CAM use was to boost the immune system, the second, to treat cancer; however these reasons varied depending on specific CAM therapy. Friends or family members and mass media were common primary information source's about CAM. A high proportion of advanced-stage breast cancer patients used CAM. Discussion with doctors was high for ingested products. Mass media was a prominent source of patient information. Credible sources of CAM information for patients and physicians are needed.
- 13 August 2002
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 2 (1) , 8
Open AccessUse of complementary/alternative therapies by women with advanced-stage breast cancer
This study sought to describe the pattern of complementary/alternative medicine (CAM) use among a group of patients with advanced breast cancer, to examine the main reasons for their CAM use, to identify patient's information sources and their communication pattern with their physicians. Face-to-face structured interviews of patients with advanced-stage breast cancer at a comprehensive oncology center. Seventy three percent of patients used CAM; relaxation/meditative techniques and herbal medicine were the most common. The most commonly cited primary reason for CAM use was to boost the immune system, the second, to treat cancer; however these reasons varied depending on specific CAM therapy. Friends or family members and mass media were common primary information source's about CAM. A high proportion of advanced-stage breast cancer patients used CAM. Discussion with doctors was high for ingested products. Mass media was a prominent source of patient information. Credible sources of CAM information for patients and physicians are needed.